Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 | Q99720 | 3/20 | 0.54 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.45 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.45 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.45 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
| ▸ | HRH3 | Q9Y5N1 | 5/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | ACHE | P22303 | 1/20 | 0.43 |
| ▸ | HTR1A | P08908 | 3/20 | 0.40 |
| ▸ | DRD2 | P14416 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14660573 | 0.85 | HRH3 (0.51) | SIGMAR1HRH3ACHEHTR1ADRD2 | |
| SCHEMBL27616211 | 0.84 | MAPT (0.60) | SIGMAR1MAPT | |
| SCHEMBL19290959 | 0.84 | MAPT (0.60) | SIGMAR1MAPT | |
| SCHEMBL18857789 | 0.76 | SIGMAR1 (0.54) | SIGMAR1OPRM1OPRD1OPRK1GAA | |
| SCHEMBL28053573 | 0.76 | SIGMAR1 (0.54) | SIGMAR1OPRM1OPRD1OPRK1GAA | |
| SCHEMBL13865770 | 0.73 | GAA (0.34) | GAADRD2 | |
| SCHEMBL14660575 | 0.73 | GBA1 (0.52) | SIGMAR1HRH3MAPTACHE | |
| SCHEMBL4513431 | 0.73 | GBA1 (0.52) | SIGMAR1HRH3MAPTACHE | |
| SCHEMBL22668719 | 0.73 | GBA1 (0.52) | SIGMAR1HRH3MAPTACHE | |
| SCHEMBL18834993 | 0.73 | MAPT (0.50) | SIGMAR1MAPTACHEHTR1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105246888-A | Imidazopyridine compounds and uses thereof | TECHNOLOGY SG L P | 2016-01-13 | — | — | CN | disclosed |